INVESTOR ALERT: Levi & Korsinsky, LLP Reminds Investors of an Investigation Involving Possible Securities Fraud Violations by the Board of Directors of Genocea Biosciences, Inc.

NEW YORK--(BUSINESS WIRE)--Levi & Korsinsky announces it has commenced an investigation of Genocea Biosciences, Inc. (NASDAQ:GNCA) concerning possible violations of federal securities laws. On September 25, 2017, Genocea disclosed that it was halting spending and activities on GEN-003 and exploring strategic alternatives for the drug. The Company also announced that it was cutting 40% of its workforce. To obtain additional information, go to:

http://www.zlkdocs.com/GNCA-Info-Request-Form-6197

or contact Joseph E. Levi, Esq. either via email at [e-mail] or by telephone at [phone], toll-free: [phone].

Levi & Korsinsky is a national firm with offices in New York, California, Connecticut and Washington D.C. The firm’s attorneys have extensive expertise in prosecuting securities litigation involving financial fraud, representing investors throughout the nation in securities and shareholder lawsuits. Attorney advertising. Prior results do not guarantee similar outcomes.